Skip to content

Autism mutations rewire protein interaction networks to drive neurodevelopmental pathology.

Aug 2026 · Science · Vol 393 6814, pp. eady4523 · 1 citation · 114 references
Medicine

TL;DR

Overall, these findings link genetic variation to protein networks and convergent neurodevelopmental dysfunction in ASD.

Abstract

Systematic mapping of protein-protein interaction (PPI) networks and determining how causal mutations rewire them in autism spectrum disorder (ASD) provide a powerful framework for uncovering disease mechanisms and therapeutic opportunities. Using affinity purification-mass spectrometry, we systematically mapped PPIs for 100 high-confidence ASD genes, uncovering more than 1800 interactions. By assessing the impact of pathogenic missense mutations, leveraging AlphaFold, and validating key findings in human-derived model systems, we identified marked convergence onto shared protein complexes in the wild-type state and convergent PPI rewiring driven by independent mutations. For example, distinct patient-derived variants in FOXP1 disrupt its interactions with FOXP4, leading to changes in cortical neurogenesis and neural activity in brain organoids. Overall, these findings link genetic variation to protein networks and convergent neurodevelopmental dysfunction in ASD.

View source

Similar papers

Open access Jul 2026

Multi-omic data integration improves the resolution of the molecular etiology of autism in a mouse model.

RNA-sequencing, 3-dimensional protein-centric chromatin conformation, and whole genome DNA methylation sequencing approaches are used to investigate hippocampal tissue from an ASD mouse model to determine if multi-omic data integration improves the resolution of key molecular pathways contributing to the complex ASD phenotype.

Carolina D Alberca, Kwangmoon Park, Ligia A. Papale et al. · 0 citations
Open access Jul 2026

X-linked SYTL4 missense variant disrupts RAB27A-dependent vesicle trafficking and synaptic transmission in autism.

The findings implicate disrupted SYTL4-RAB27A-dependent vesicle trafficking in ASD pathogenesis and identify SYTL4 and RAB27A as previously unrecognized contributors to autism-associated synaptic deficits and behavior.

Yang Liao, Shuju Zhang, Xiaolei Zhang et al. · 0 citations

Molecules and Cells

Tae-Hwan Park, I. Koh, S. Sung et al. · 0 citations
Aug 2026

Identification of EIF4A1 as a candidate molecular indicator of autism spectrum disorder using integrative bioinformatic and biological methods.

This study integrated mRNA expression profiles from five post-mortem brain tissue GEO datasets to identify ASD-associated genes and found that EIF4A1 mRNA expression was significantly elevated in ASD subjects and rescued by treatment with the antipsychotics olanzapine or risperidone.

Siru Dai, Kaiyang Zou, Guosen Lv et al. · 0 citations
2026

Shared molecular dysregulation across neuropsychiatric disorders reveals candidate therapeutic targets.

A cross-disorder transcriptomic framework was applied to identify shared molecular dysregulation across ASD, BD, and SCZ and identified 20 high-confidence recurrent genes, with pronounced transcriptional convergence observed between BD and SCZ.

Supraja Mohan, Prasanna Kumar Selvam, Karthick Vasudevan · 0 citations
Open access Jul 2026

Mapping lncRNAs onto multilevel mRNA co‑expression modules in autism.

The findings establish MSCN as a scalable framework for decomposing ASD mRNA co-expression architecture, provide a hypothesis-generating resource linking coding and noncoding transcriptomic alterations, and help prioritize these relationships for future validation.

Chen-Ling Lee, G. Hu, Yi-Pei Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.